These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34930125)

  • 1. The role of matrix metalloproteinases in patients with pulmonary hypertension: data from a prospective study.
    Marc A; Pop C; Sitar-Taut AV; Budisan L; Berindan-Neagoe I; Pop D
    BMC Cardiovasc Disord; 2021 Dec; 21(1):607. PubMed ID: 34930125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension.
    Fijalkowska A; Kurzyna M; Torbicki A; Szewczyk G; Florczyk M; Pruszczyk P; Szturmowicz M
    Chest; 2006 May; 129(5):1313-21. PubMed ID: 16685024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating matrix metalloproteinase-2 but not matrix metalloproteinase-3, matrix metalloproteinase-9, or tissue inhibitor of metalloproteinase-1 predicts outcome in patients with congestive heart failure.
    George J; Patal S; Wexler D; Roth A; Sheps D; Keren G
    Am Heart J; 2005 Sep; 150(3):484-7. PubMed ID: 16169329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Plasma Matrix Metalloproteinase and Tissue Inhibitors of Matrix Metalloproteinase Levels With Adverse Treatment Outcomes Among Patients With Pulmonary Tuberculosis.
    Kumar NP; Moideen K; Nancy A; Viswanathan V; Thiruvengadam K; Sivakumar S; Hissar S; Nair D; Banurekha VV; Kornfeld H; Babu S
    JAMA Netw Open; 2020 Dec; 3(12):e2027754. PubMed ID: 33258908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-terminal-pro-B type natriuretic peptide as a useful tool to evaluate pulmonary hypertension and cardiac function in CDH infants.
    Baptista MJ; Rocha G; Clemente F; Azevedo LF; Tibboel D; Leite-Moreira AF; Guimarães H; Areias JC; Correia-Pinto J
    Neonatology; 2008; 94(1):22-30. PubMed ID: 18160811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of plasma NT-proBNP levels as a biomarker in the assessment of cardiac involvement and pulmonary hypertension in patients with sarcoidosis.
    Handa T; Nagai S; Ueda S; Chin K; Ito Y; Watanabe K; Tanizawa K; Tamaya M; Mishima M; Izumi T
    Sarcoidosis Vasc Diffuse Lung Dis; 2010 Jul; 27(1):27-35. PubMed ID: 21086902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum endothelin-1 and NT-proBNP, but not ADMA, endoglin and TIMP-1 levels, reflect impaired right ventricular function in patients with systemic sclerosis.
    Ciurzyński M; Bienias P; Irzyk K; Kostrubiec M; Bartoszewicz Z; Siwicka M; Stelmaszczyk-Emmel A; Górska E; Demkow U; Pruszczyk P
    Clin Rheumatol; 2014 Jan; 33(1):83-9. PubMed ID: 23942766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of predictive value of NT-proBNP, sST2 and MMPs in heart failure patients with different ejection fractions.
    Pan W; Yang D; Yu P; Yu H
    BMC Cardiovasc Disord; 2020 Apr; 20(1):208. PubMed ID: 32354356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No changes in N-terminal pro-brain natriuretic peptide in a longitudinal cohort of patients with systemic sclerosis-associated pulmonary arterial hypertension on therapy with bosentan.
    Rotondo C; Praino E; Nivuori M; di Serio F; Lapadula G; Iannone F
    Int J Rheum Dis; 2017 Jan; 20(1):90-96. PubMed ID: 26218502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy.
    Roldán V; Marín F; Gimeno JR; Ruiz-Espejo F; González J; Feliu E; García-Honrubia A; Saura D; de la Morena G; Valdés M; Vicente V
    Am Heart J; 2008 Jul; 156(1):85-91. PubMed ID: 18585501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CHA2DS2-VASc score and blood biomarkers to identify patients with atrial high-rate episodes and paroxysmal atrial fibrillation.
    Wakula P; Neumann B; Kienemund J; Thon-Gutschi E; Stojakovic T; Manninger M; Scherr D; Scharnagl H; Kapl M; Pieske B; Heinzel FR
    Europace; 2017 Apr; 19(4):544-551. PubMed ID: 28431065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left atrial volume and N-terminal pro-B type natriuretic peptide are associated with elevated pulmonary artery pressure in patients with systemic sclerosis.
    Dimitroulas T; Giannakoulas G; Papadopoulou K; Sfetsios T; Karvounis H; Dimitroula H; Parcharidou D; Koliakos G; Garyfallos A; Styliadis I; Settas L
    Clin Rheumatol; 2010 Sep; 29(9):957-64. PubMed ID: 20526641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of matrix metalloproteinases and their tissue inhibitors as potential biomarkers of left ventricular remodelling in the athlete's heart.
    Vianello A; Caponi L; Franzoni F; Galetta F; Rossi M; Taddei M; Malvaldi G; Pietrini P; Santoro G
    Clin Sci (Lond); 2009 Jul; 117(4):157-64. PubMed ID: 19196241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in biomarkers in patients with heart failure with a reduced vs a preserved left ventricular ejection fraction.
    de Denus S; Lavoie J; Ducharme A; O'Meara E; Racine N; Sirois MG; Neagoe PE; Zhu L; Rouleau JL; White M
    Can J Cardiol; 2012; 28(1):62-8. PubMed ID: 22104539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-terminal pro-brain natriuretic peptide is a useful prognostic marker in patients with pre-capillary pulmonary hypertension and renal insufficiency.
    Harbaum L; Hennigs JK; Baumann HJ; Lüneburg N; Griesch E; Bokemeyer C; Grünig E; Klose H
    PLoS One; 2014; 9(4):e94263. PubMed ID: 24751887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B-type natriuretic peptide as a parameter for pulmonary hypertension in children. A systematic review.
    Ten Kate CA; Tibboel D; Kraemer US
    Eur J Pediatr; 2015 Oct; 174(10):1267-75. PubMed ID: 26298682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of NT-proBNP with severity of heart valve disease in a medical patient population presenting with acute dyspnea or peripheral edema.
    Behnes M; Lang S; Breithardt OA; Kaden JJ; Haghi D; Ahmad-Nejad P; Elmas E; Wolpert C; Borggrefe M; Neumaier M; Brueckmann M
    J Heart Valve Dis; 2008 Sep; 17(5):557-65. PubMed ID: 18980090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurohormonal activation in patients with systemic sclerosis-related pulmonary arterial hypertension.
    Dimitroulas T; Giannakoulas G; Karvounis H; Sfetsios T; Koliakos G; Parcharidis G; Settas L
    Int J Cardiol; 2007 Sep; 121(1):135-7. PubMed ID: 17088004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations of circulating natriuretic peptides with haemodynamics in precapillary pulmonary hypertension.
    Kaiser R; Grotemeyer K; Lepper P; Stokes C; Bals R; Wilkens H
    Respir Med; 2015 Sep; 109(9):1213-23. PubMed ID: 26194624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma N-terminal pro-brain natriuretic peptide: a prognostic marker in patients with chronic obstructive pulmonary disease.
    Chi SY; Kim EY; Ban HJ; Oh IJ; Kwon YS; Kim KS; Kim YI; Kim YC; Lim SC
    Lung; 2012 Jun; 190(3):271-6. PubMed ID: 22246552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.